Correction: ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Correction: ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Saved in:

Bibliographic Details
Main Authors:	Lin Hu, Jiarui Wei, Yue Zhang, Ziyuan Wang, Junming Tang, Jian Tang, Yujiu Gao, Xiaoqiao Zhang, Yifan Li, Yantong Liu, Shinan Ma, Xingrong Guo, Qiufang Zhang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2025-06-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-025-07731-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy
by: Lin Hu, et al.
Published: (2022-07-01)

ANGPTL8 promotes adipogenic differentiation of mesenchymal stem cells: potential role in ectopic lipid deposition
by: Jian Tang, et al.
Published: (2022-08-01)

Corrigendum: ANGPTL8 promotes adipogenic differentiation of mesenchymal stem cells: potential role in ectopic lipid deposition
by: Jian Tang, et al.
Published: (2025-05-01)

Liver-specific expression of ANGPTL8 promotes Alzheimer’s disease progression through activating microglial pyroptosis
by: Jiarui Wei, et al.
Published: (2025-07-01)

Protein phosphatases in pathological cardiac hypertrophy
by: ZHANG Xutao, et al.
Published: (2024-04-01)

GDM links to increased neonatal myocardial hypertrophy via ANGPTL7: prospective cohort study
by: Weihua Jian, et al.
Published: (2025-12-01)

TRIM26 exacerbates pathological cardiac hypertrophy by activating TAK1
by: Xiaochuang Xia, et al.
Published: (2025-01-01)

SLC26A4 regulates autophagy and activates the NLRP3 inflammasome to mediate pathological cardiac hypertrophy
by: Li-qun Tang, et al.
Published: (2025-04-01)

Cardiomyocyte‐Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination
by: Lingfeng Zhong, et al.
Published: (2025-06-01)

Emerging Role of Targeting Deubiquitinating Enzymes to Inhibit Pathological Cardiac Hypertrophy
by: Ren Ping Liu, et al.
Published: (2025-03-01)

Impact of oxygen concentration changes on ANGPTL8 expression of human pulmonary artery endothelial cells
by: ZHANG Zongli, LI Tao, MA Jingwen, ZHANG Jiaxin, LI Xingchao, XI Shibing
Published: (2025-01-01)

QRICH1 regulates ATF6 transcription to affect pathological cardiac hypertrophy progression
by: Lihui Zhang, et al.
Published: (2025-05-01)

The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer of β-Cell Proliferation
by: Mohamed Abu-Farha, et al.
Published: (2016-01-01)

Vaspin alleviates pathological cardiac hypertrophy by regulating autophagy-dependent myocardial senescence
by: Haiying Rui, et al.
Published: (2024-03-01)

Cardiac LXRα protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization
by: Megan V Cannon, et al.
Published: (2015-07-01)

The significance of ANGPTL3 and ANGPTL4 proteins in the development of dyslipidemia in Type 2 diabetes mellitus
by: Rik Swarnakar, et al.
Published: (2025-03-01)

SGLT2 inhibitor downregulates ANGPTL4 to mitigate pathological aging of cardiomyocytes induced by type 2 diabetes
by: Yun Wen, et al.
Published: (2024-12-01)

Adipocytes-induced ANGPTL4/KLF4 axis drives glycolysis and metastasis in triple-negative breast cancer
by: Dou Yin, et al.
Published: (2025-07-01)

Adipocyte Angptl8 deletion improves glucose and energy metabolism and obesity associated inflammation in mice
by: Anindya Ghosh, et al.
Published: (2024-12-01)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
by: Si-Chi Xu, et al.
Published: (2017-01-01)

Determinants of left atrial reservoir strain and diagnostic potential for cardiac amyloidosis in pathological left ventricular hypertrophy
by: Katsuji Inoue, et al.
Published: (2025-03-01)

ANGPTL3 orchestrates hepatic fructose sensing and metabolism
by: Meng Zhao, et al.
Published: (2025-07-01)

Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-09-01)

Novel model of cardiac hypertrophy with cardiorenal dysfunction
by: Amanda de Almeida Silva, et al.
Published: (2025-07-01)

Extracellular vesicular microRNAs and cardiac hypertrophy
by: Hai Hu, et al.
Published: (2025-01-01)

Elevated serum asprosin and ANGPTL8 gene expression as novel biomarkers for the diagnosis and prognosis of acute coronary syndrome
by: Zainulabdin Abdulnabi Abdulah Albreej, et al.
Published: (2025-04-01)

Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women
by: Danlan Pu, et al.
Published: (2019-01-01)

Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways
by: Mingyu Zhang, et al.
Published: (2025-03-01)

Deubiquitinase Ubiquitin‐Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β‐Activated Kinase 1
by: Xi Jiang, et al.
Published: (2025-03-01)

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis
by: Farah Abdelhameed, et al.
Published: (2025-04-01)

Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways
by: Wen-Ying Wei, et al.
Published: (2016-01-01)

Adipose Factor ANGPTL4: Its Role in Aging Mechanisms and Associated Diseases
by: Wang X, et al.
Published: (2025-06-01)

MICU3 Regulates Mitochondrial Calcium and Cardiac Hypertrophy
by: Barbara Roman, et al.
Published: (2025-06-01)

Temporal analysis of doxorubicin-induced cardiac toxicity and hypertrophy
by: Yu-Te Lin, et al.
Published: (2025-07-01)

Circ-0001283 Aggravates Cardiac Hypertrophy by Targeting Myosin Light Chain 3 Protein
by: Wenjing Wang, et al.
Published: (2025-01-01)

Electrophysiological characteristics of pressure overload-induced cardiac hypertrophy and its influence on ventricular arrhythmias.
by: Xiaowei Chen, et al.
Published: (2017-01-01)

ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY
by: H. Yokoyama, et al.
Published: (2011-08-01)

Targeting cardiac hypertrophy through a nuclear co‐repressor
by: Andrea Grund, et al.
Published: (2019-10-01)

Exercise-triggered cardiac remodeling: AKIP1 as a novel mediator of physiological hypertrophy
by: Jiahui Li, et al.
Published: (2025-06-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
by: A. N. Meshkov, et al.
Published: (2022-11-01)